PLoS ONE (Jan 2019)

Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study.

  • Helen Dolengevich-Segal,
  • Alicia Gonzalez-Baeza,
  • Jorge Valencia,
  • Eulalia Valencia-Ortega,
  • Alfonso Cabello,
  • Maria Jesus Tellez-Molina,
  • Maria Jesus Perez-Elias,
  • Regino Serrano,
  • Leire Perez-Latorre,
  • Luz Martin-Carbonero,
  • Sari Arponen,
  • Jose Sanz-Moreno,
  • Sara De la Fuente,
  • Otilia Bisbal,
  • Ignacio Santos,
  • Jose Luis Casado,
  • Jesus Troya,
  • Miguel Cervero-Jimenez,
  • Sara Nistal,
  • Guillermo Cuevas,
  • Javier Correas-Lauffer,
  • Marta Torrens,
  • Pablo Ryan,
  • U-SEX GESIDA 9416 Study

DOI
https://doi.org/10.1371/journal.pone.0220272
Journal volume & issue
Vol. 14, no. 12
p. e0220272

Abstract

Read online

OBJECTIVES:Sexualized intravenous drug use, also known as slamsex, seems to be increasing among HIV-positive men who have sex with men (MSM). Physical and psychopathological symptoms have previously been reported in this population, although research on the subject of slamsex is scarce. The objectives of our study were to describe the psychopathological background of a sample of HIV-positive MSM who engaged in slamsex during the previous year and to compare physical, psychopathological, and drug-related symptoms between these participants and those who engaged in non-injecting sexualized drug use. DESIGN AND METHODS:Participants (HIV-positive MSM) were recruited from the U-Sex study in 22 HIV clinics in Madrid during 2016-17. All participants completed an anonymous cross-sectional online survey on sexual behavior and recreational drug use. When participants met the inclusion criteria, physicians offered them the opportunity to participate and gave them a card with a unique code and a link to access the online survey. The present analysis is based on HIV-positive MSM who had engaged in slamsex and non-injecting sexualized drug use. RESULTS:The survey sample comprised 742 participants. Of all the participants who completed the survey, 216 (29.1%) had engaged in chemsex, and of these, 34 (15.7%) had engaged in slamsex. Participants who engaged in slamsex were more likely to have current psychopathology (depression, anxiety, and drug-related disorders) than participants who engaged in non-injecting sexualized drug use. In addition, participants who engaged in slamsex more frequently reported high-risk sexual behaviors and polydrug use and were more often diagnosed with sexually transmitted infections (STIs) and hepatitis C than those who did not inject drugs. Compared with participants who did not inject drugs, participants who engaged in slamsex experienced more severe drug-related symptoms (withdrawal and dependence), symptoms of severe intoxication (loss of consciousness), and severe psychopathological symptoms during or after slamsex (eg, paranoid thoughts and suicidal behaviors). CONCLUSION:Slamsex is closely associated with current psychiatric disorders and severe drug-related and psychiatric symptoms.